Product Information | Nalu Medical

Neurostimulation has been used for many years and recent advances make it even more helpful for more patients.

An implantable pulse generator (IPG) generates mild electrical impulses to interrupt pain signals before they get to your brain. The other part of the system that gets implanted in your body is called a lead. The lead carries the pulses generated by the IPG to the spinal cord or affected nerve to block the pain signal. This will be placed near the area your physician determines to be the one most likely to resolve or lessen your chronic pain.

About the Nalu Neurostimulation System

The Nalu Neurostimulation System is currently FDA cleared for SCS and PNS indications. The Nalu micro-IPG leverages proprietary advanced microelectronics to produce a pain management system that effectively reduces chronic intractable pain while minimizing interference with the patient’s life. Utilizing an external battery and a micro-IPG with the smallest footprint among commercially available IPGs may mitigate some of the most troublesome aspects of implantable neurostimulation therapy.

The Nalu Neurostimulation System is truly Engineered to be more.

• A smaller, less invasive implant: Up to 27x smaller than the largest commercially available implantable pulse generator (IPG).
• A battery-free, micro-IPG: Power is externally supplied with a replaceable, wearable Therapy Disc, which eliminates the need for an implanted battery and battery replacement surgeries.
• Upgrades without surgery: Software can be upgraded wirelessly and without surgery.
• Long-lasting use: The micro-IPG has an FDA-cleared label with an expected service life of 18 years for long-term management of chronic intractable pain

Nalu Therapy Overview

Nalu Therapy Overview from Nalu Medical on Vimeo

Nalu has been repeatedly recognized for its revolutionary technology and innovation, including being named as one of the top 100 new products in the world by R&D Magazine. Nalu was also named Gold Winner of the 2021 Medical Design Excellence Award and winner of MedTech Visionaries Award for Best MedTech Company and Best Medical Device in the field of neurology.

Engineered to Be More ™:

durABLE

• Nalu micro-IPG has the longest service life among commercially available IPGs in the US–18 years
• Eliminates battery-replacement surgeries
• Highly configurable microchip enables upgrade of system capabilities when approved

livABLE

• Designed to fit patient’s lifestyle
• Wearable power and control disc is easy to manage
• Therapy Disc is easily changed for optimum flexibility
• Smartphone control permits discreet system management
• Patients report the system is easy to use1

comfortABLE

• Rated comfortable by patients1-3
• Patients describe the Therapy Disc as virtually unnoticeable1
• Nalu micro-IPG allows a minimally invasive procedure

manageABLE

• Extensive menu of therapy options
• Patient discreetly controls system from smartphone
• No need for separate device for patient remote control
• Integrated power and control disc helps simplify system management
• Feedback controlled energy transfer for consistent therapy output

upgradeABLE

• Flexible nPower™ architecture redefines system upgradeability
• System capabilities can be expanded by routine software updates
• External components can be upgraded as technology evolves

adaptABLE

• FDA-cleared for both SCS and PNS indications
• Nalu micro-IPG provides more surgical options
• Wide range of therapeutic options
• Advanced control from familiar smartphone

Additional Resources

User Manual

Safety Information

Patient Resources

Provider Resources

More Information

[Contact Nalu Medical](/content/contact-us/ "Contact Us"/index.html)

1. Staats P, Hartley L, Mishra LN, et al. Human Comfort and Feasibility Data from a New, Miniaturized SCS System. presented at: North American Neuromodulation Society (NANS) Meeting; January 17-January 20 2019; Las Vegas.

2. Amirdelfan K, Levy R, Poree L, Staats P. Evaluation of a New, Battery-Free Microstimulator SCS System: Comfort and Ease-of-Use Data (nPower™ study). presented at: North American Neuromodulation Society (NANS) Meeting; January 23-January 26 2020; Las Vegas.

3. Amirdelfan K, Levy R, Poree L, et al. Evaluation Of a New, Battery-Free Micro-Implantable Pulse Generator SCS System: Patient Choice, Comfort and Ease-of-Use Data. presented at: North American Neuromodulation Society (NANS) Meeting; January 23-January 26 2020; Las Vegas.